George Zikos
Optometrist · New York, NYNPI 1740430941
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $67,400 of the $72,250 with a category attached, or 93.3%. Johnson & Johnson Vision Care, Inc. accounts for 94.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $67,544 and has fallen 99.0% since, to $708 in 2025. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $422.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$68K
- Sun Pharmaceutical Industries Inc.$1K
- Oyster Point Pharma, Inc.$1K
- Bausch & Lomb Americas Inc.$998
- Coopervision Inc.$358
- Alcon$199
- plus $562 from 9 others
Across 61 payments — averaging $15,833 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Vision Care, Inc.$573K
- Oyster Point Pharma, Inc.$340K
- Alcon Research LLC$53K
What the payments were for
- Consulting fees$67,40093%
- Food & beverage$4,8507%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 14 | $67,931 |
| Sun Pharmaceutical Industries Inc. | 62 | $1,177 |
| Oyster Point Pharma, Inc. | 31 | $1,024 |
| Bausch & Lomb Americas Inc. | 25 | $998 |
| Coopervision Inc. | 12 | $358 |
| Alcon | 8 | $199 |
| Tarsus Pharmaceuticals, Inc. | 6 | $152 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $100 |
| Harrow Eye, LLC | 1 | $83 |
| AbbVie(2 entities) | 2 | $55 |
| Sight Sciences, Inc. | 2 | $42 |
| Visioneering Technologies, Inc. | 1 | $40 |
| Kala Pharmaceuticals, Inc. | 2 | $39 |
| Mylan Inc. | 2 | $28 |
| Dompe US, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,250 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in New York
- Susan ResnickNew York$463K
- Denise WhittamNew York$343K
- Jennifer TsaiNew York$275K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
- Richard MadonnaNew York$75K
- Craig TischNew York$59K
- Arthur JungNew York$50K
- Milly MuiNew York$46K
- Arkady SelenowNew York$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.